- Home
- XERS vs ETD Comparison
XERS vs ETD Comparison
Compare XERS & ETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- ETD
- Stock Information
- Founded
- XERS 2005
- ETD 1932
- Country
- XERS United States
- ETD United States
- Employees
- XERS 394
- ETD N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- ETD Home Furnishings
- Sector
- XERS Health Care
- ETD Consumer Discretionary
- Exchange
- XERS Nasdaq
- ETD Nasdaq
- Market Cap
- XERS 1.3B
- ETD 763.7M
- IPO Year
- XERS 2018
- ETD 1993
- Fundamental
- Price
- XERS $7.93
- ETD $29.57
- Analyst Decision
- XERS Strong Buy
- ETD Hold
- Analyst Count
- XERS 7
- ETD 2
- Target Price
- XERS $8.00
- ETD $30.00
- AVG Volume (30 Days)
- XERS 3.5M
- ETD 302.2K
- Earning Date
- XERS 08-07-2025
- ETD 07-30-2025
- Dividend Yield
- XERS N/A
- ETD 6.05%
- EPS Growth
- XERS N/A
- ETD N/A
- EPS
- XERS N/A
- ETD 2.01
- Revenue
- XERS $246,025,000.00
- ETD $614,649,000.00
- Revenue This Year
- XERS $43.89
- ETD $0.62
- Revenue Next Year
- XERS $20.40
- ETD $4.06
- P/E Ratio
- XERS N/A
- ETD $14.88
- Revenue Growth
- XERS 35.62
- ETD N/A
- 52 Week Low
- XERS $2.48
- ETD $24.55
- 52 Week High
- XERS $8.02
- ETD $33.77
- Technical
- Relative Strength Index (RSI)
- XERS 80.36
- ETD 52.63
- Support Level
- XERS $7.27
- ETD $29.65
- Resistance Level
- XERS $8.02
- ETD $31.41
- Average True Range (ATR)
- XERS 0.32
- ETD 0.67
- MACD
- XERS 0.03
- ETD -0.02
- Stochastic Oscillator
- XERS 93.99
- ETD 42.34
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About ETD Ethan Allen Interiors Inc.
Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.